According to Seagen 's latest financial reports the company's total liabilities are $1.08 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $0.87 B | 33.04% |
2021-12-31 | $0.65 B | 27.62% |
2020-12-31 | $0.51 B | 55.59% |
2019-12-31 | $0.32 B | 43.68% |
2018-12-31 | $0.22 B | 14.48% |
2017-12-31 | $0.20 B | -1.92% |
2016-12-31 | $0.20 B | -2.33% |
2015-12-31 | $0.20 B | -15.7% |
2014-12-31 | $0.24 B | -2.2% |
2013-12-31 | $0.25 B | 3.44% |
2012-12-31 | $0.24 B | 18.85% |
2011-12-31 | $0.20 B | 22.53% |
2010-12-31 | $0.16 B | -7.53% |
2009-12-31 | $0.18 B | 67.56% |
2008-12-31 | $0.10 B | 14.97% |
2007-12-31 | $94.54 M | 899.3% |
2006-12-31 | $9.46 M | -35.03% |
2005-12-31 | $14.56 M | -4.68% |
2004-12-31 | $15.27 M | 114.52% |
2003-12-31 | $7.12 M | 22.06% |
2002-12-31 | $5.83 M | 147.51% |
2001-12-31 | $2.35 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $128.53 B | 11,759.41% | ๐บ๐ธ USA |
AbbVie ABBV | $140.82 B | 12,893.34% | ๐บ๐ธ USA |
Biogen BIIB | $11.35 B | 947.63% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $82.48 B | 7,510.26% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $57.22 B | 5,179.76% | ๐ฌ๐ง UK |
Spectrum Pharmaceuticals
SPPI | $80.87 M | -92.54% | ๐บ๐ธ USA |
ImmunoGen
IMGN | $0.26 B | -75.96% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | $30.23 M | -97.21% | ๐บ๐ธ USA |